primal treatment group:none

2 trials

Sponsors

the First Affiliated Hospital of University of Science and Technology of China, Ethics Committee of the First Affiliated Hospital of University of Science and Technology of China

Conditions

high grade serous ovarian cancer

Early Phase 1

Clinical study on screening and identification of tumor derived eccDNA for predicting HRD status of high-grade serous ovarian cancer (DAISY2)

Active, not recruitingChiCTR2200066898

the First Affiliated Hospital of University of Science and Technology of Chinahigh grade serous ovarian cancer

Start: 2022-12-25Updated: 2023-05-15

Clinical study on prediction of minimal residual lesions (MRD) in high-grade serous ovarian cancer by extrachromosomal circular DNA (eccDNA) (DAISY1)

Active, not recruitingChiCTR2200066986

Ethics Committee of the First Affiliated Hospital of University of Science and Technology of Chinahigh grade serous ovarian cancer

Start: 2022-12-25Updated: 2023-05-15